Cellular uptake of the tat protein from human immunodeficiency virus - PubMed (original) (raw)
Cellular uptake of the tat protein from human immunodeficiency virus
A D Frankel et al. Cell. 1988.
Abstract
While developing an assay to measure the activity of the tat protein from human immunodeficiency virus 1 (HIV-1), we discovered that the purified protein could be taken up by cells growing in tissue culture and subsequently trans-activate the viral promoter. Trans-activation is dramatically increased by a variety of lysosomotrophic agents. For example, trans-activation can be detected at tat concentrations as low as 1 nM in the presence of chloroquine. Experiments using radioactive protein show that tat becomes localized to the nucleus after uptake and suggest that chloroquine protects tat from proteolytic degradation. These results raise the possibility that, under some conditions, tat might act as a viral growth factor to stimulate viral replication in latently infected cells or alter expression of cellular genes.
Similar articles
- Cellular uptake of the tat protein from human immunodeficiency virus.
[No authors listed] [No authors listed] Dis Markers. 1990 Jan-Feb;8(1):33-4. Dis Markers. 1990. PMID: 2178855 No abstract available. - Tat transactivation of the human immunodeficiency virus type 1 promoter is influenced by basal promoter activity and the simian virus 40 origin of DNA replication.
Kessler M, Mathews MB. Kessler M, et al. Proc Natl Acad Sci U S A. 1991 Nov 15;88(22):10018-22. doi: 10.1073/pnas.88.22.10018. Proc Natl Acad Sci U S A. 1991. PMID: 1658792 Free PMC article. - Paracrine activation of the HIV-1 LTR promoter by the viral Tat protein is mechanistically similar to trans-activation within a cell.
Verhoef K, Klein A, Berkhout B. Verhoef K, et al. Virology. 1996 Nov 15;225(2):316-27. doi: 10.1006/viro.1996.0606. Virology. 1996. PMID: 8918918 - Regulation of expression of human immunodeficiency virus.
Pavlakis GN, Felber BK. Pavlakis GN, et al. New Biol. 1990 Jan;2(1):20-31. New Biol. 1990. PMID: 2078551 Review. - Tackling Tat.
Karn J. Karn J. J Mol Biol. 1999 Oct 22;293(2):235-54. doi: 10.1006/jmbi.1999.3060. J Mol Biol. 1999. PMID: 10550206 Review.
Cited by
- Structural Insights into the Mechanism of HIV-1 Tat Secretion from the Plasma Membrane.
Ghanam RH, Eastep GN, Saad JS. Ghanam RH, et al. J Mol Biol. 2023 Jan 30;435(2):167880. doi: 10.1016/j.jmb.2022.167880. Epub 2022 Nov 10. J Mol Biol. 2023. PMID: 36370804 Free PMC article. - Cationic Cell-Penetrating Peptides Are Potent Furin Inhibitors.
Ramos-Molina B, Lick AN, Nasrolahi Shirazi A, Oh D, Tiwari R, El-Sayed NS, Parang K, Lindberg I. Ramos-Molina B, et al. PLoS One. 2015 Jun 25;10(6):e0130417. doi: 10.1371/journal.pone.0130417. eCollection 2015. PLoS One. 2015. PMID: 26110264 Free PMC article. - Induced pluripotent stem cells as a source of hepatocytes.
Sauer V, Roy-Chowdhury N, Guha C, Roy-Chowdhury J. Sauer V, et al. Curr Pathobiol Rep. 2014 Mar;2(1):11-20. doi: 10.1007/s40139-013-0039-2. Curr Pathobiol Rep. 2014. PMID: 25650171 Free PMC article. - Immunoinformatics Design of Multi-Epitope Peptide-Based Vaccine Against Schistosoma mansoni Using Transmembrane Proteins as a Target.
Sanches RCO, Tiwari S, Ferreira LCG, Oliveira FM, Lopes MD, Passos MJF, Maia EHB, Taranto AG, Kato R, Azevedo VAC, Lopes DO. Sanches RCO, et al. Front Immunol. 2021 Mar 2;12:621706. doi: 10.3389/fimmu.2021.621706. eCollection 2021. Front Immunol. 2021. PMID: 33737928 Free PMC article. - Effects of HCV on basal and tat-induced HIV LTR activation.
Sengupta S, Powell E, Kong L, Blackard JT. Sengupta S, et al. PLoS One. 2013 Jun 10;8(6):e64956. doi: 10.1371/journal.pone.0064956. Print 2013. PLoS One. 2013. PMID: 23762271 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources